John S. L. Parker
- Infectious Diseases top 1%
- Genetics top 1%
- Animal Science and Zoology top 0.5%
- Molecular Biology top 10%
- Cardiology and Cardiovascular Medicine top 5%
- Co-authors
- Colin R. ParrishMax L. NibertTeresa J. BroeringJong‐Hwa KimWendy S. WeichertRobert J. OssiboffKarthic ChandranDai Wang
- Topics
- Viral gastroenteritis research and epidemiology (30 papers)Virus-based gene therapy research (24 papers)Animal Virus Infections Studies (17 papers)
- Partner nations
- United StatesSpainCanada
In The Last Decade
John S. L. Parker
47 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 97
- Infectious Diseases 1.5k
- Genetics 1.3k
- Animal Science and Zoology 952
- Molecular Biology 723
- Cardiology and Cardiovascular Medicine 379
Countries citing papers authored by John S. L. Parker
This map shows the geographic impact of John S. L. Parker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John S. L. Parker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John S. L. Parker more than expected).
Fields of papers citing papers by John S. L. Parker
This network shows the impact of papers produced by John S. L. Parker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John S. L. Parker. The network helps show where John S. L. Parker may publish in the future.
Co-authorship network of co-authors of John S. L. Parker
This figure shows the co-authorship network connecting the top 25 collaborators of John S. L. Parker. A scholar is included among the top collaborators of John S. L. Parker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John S. L. Parker. John S. L. Parker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 10 | |
| 2 | 7 | |
| 3 | 64 | |
| 4 | 43 | |
| 5 | 53 | |
| 6 | 31 | |
| 7 | 3 | |
| 8 | 46 | |
| 9 | 25 | |
| 10 | 59 | |
| 11 | 6 | |
| 12 | 58 | |
| 13 | 52 | |
| 14 | 46 | |
| 15 | 56 | |
| 16 | 24 | |
| 17 | 78 | |
| 18 | 52 | |
| 19 | 87 | |
| 20 | 76 |
About John S. L. Parker
John S. L. Parker is a scholar working on Infectious Diseases, Animal Science and Zoology and Genetics, having authored 48 papers that have together received 2.5k indexed citations. Recurring topics across this work include Viral gastroenteritis research and epidemiology (30 papers), Virus-based gene therapy research (24 papers) and Animal Virus Infections Studies (17 papers). The work is most often cited by research in Animal Science and Zoology (952 citations), Infectious Diseases (1.5k citations) and Genetics (1.3k citations). John S. L. Parker has collaborated with scholars based in United States, Spain and Canada. Frequent co-authors include Colin R. Parrish, Max L. Nibert, Teresa J. Broering, Jong‐Hwa Kim, Wendy S. Weichert, Robert J. Ossiboff, Karthic Chandran, Dai Wang, William J. Murphy and Stephen J. O’Brien. Their work appears in journals such as Journal of Biological Chemistry, Nature Biotechnology and Applied and Environmental Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.